<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>ABL, Sa - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/129867.xml</link>
<description>ABL, Sa - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Advanced Biological Laboratories SA (ABL, S.A) Licenses Stanford HIV Resistance Interpretation Algorithm - Adds to Viroscore Suite Genetic Sequence Database and Analysis Engine</title>
     <link>http://www.prweb.com/releases/2005/03/prweb223628.htm</link><description>   <![CDATA[ <P>ABL to integrate the Stanford Algorithm with the 5 algorithms currently used in its "global resistance interpretation" report offered in the ViroScore Suite Diagnostic Product. (PRWeb Mar 30, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/03/prweb223628.htm">http://www.prweb.com/releases/2005/03/prweb223628.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/03/prweb223628.htm</guid>
        </item>
<item>
     <title>Advanced Biological Laboratories SA (ABL, SA) Acquires Majority Control of TherapyEdge Inc.; Acquisition Adds Key Biotech Patent and Related Products.</title>
     <link>http://www.prweb.com/releases/2005/02/prweb211479.htm</link><description>   <![CDATA[ <P>ABL to integrate TherapyEdge-HIV product functionality into existing product line and license IP to leading diagnostic and laboratory companies. (PRWeb Feb 22, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/02/prweb211479.htm">http://www.prweb.com/releases/2005/02/prweb211479.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/02/prweb211479.htm</guid>
        </item>
</channel>
</rss>